GT Biopharma (GTBP) Competitors $3.09 -0.10 (-3.13%) (As of 11:00 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends GTBP vs. JAGX, KPRX, CYAD, TTPH, UBX, RNXT, NAII, MRKR, DRRX, and LGVNShould you be buying GT Biopharma stock or one of its competitors? The main competitors of GT Biopharma include Jaguar Health (JAGX), Kiora Pharmaceuticals (KPRX), Celyad Oncology (CYAD), Tetraphase Pharmaceuticals (TTPH), Unity Biotechnology (UBX), RenovoRx (RNXT), Natural Alternatives International (NAII), Marker Therapeutics (MRKR), DURECT (DRRX), and Longeveron (LGVN). These companies are all part of the "medical" sector. GT Biopharma vs. Jaguar Health Kiora Pharmaceuticals Celyad Oncology Tetraphase Pharmaceuticals Unity Biotechnology RenovoRx Natural Alternatives International Marker Therapeutics DURECT Longeveron Jaguar Health (NASDAQ:JAGX) and GT Biopharma (NASDAQ:GTBP) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, community ranking, analyst recommendations and earnings. Which has better valuation & earnings, JAGX or GTBP? GT Biopharma has lower revenue, but higher earnings than Jaguar Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJaguar Health$9.76M0.92-$41.30MN/AN/AGT BiopharmaN/AN/A-$7.60MN/AN/A Which has more volatility & risk, JAGX or GTBP? Jaguar Health has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Comparatively, GT Biopharma has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500. Is JAGX or GTBP more profitable? GT Biopharma has a net margin of 0.00% compared to Jaguar Health's net margin of -360.13%. GT Biopharma's return on equity of -257.47% beat Jaguar Health's return on equity.Company Net Margins Return on Equity Return on Assets Jaguar Health-360.13% -326.62% -67.02% GT Biopharma N/A -257.47%-131.09% Do institutionals & insiders have more ownership in JAGX or GTBP? 12.0% of Jaguar Health shares are owned by institutional investors. Comparatively, 8.2% of GT Biopharma shares are owned by institutional investors. 0.0% of Jaguar Health shares are owned by insiders. Comparatively, 10.9% of GT Biopharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media favor JAGX or GTBP? In the previous week, Jaguar Health had 5 more articles in the media than GT Biopharma. MarketBeat recorded 6 mentions for Jaguar Health and 1 mentions for GT Biopharma. Jaguar Health's average media sentiment score of 0.70 beat GT Biopharma's score of 0.00 indicating that Jaguar Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jaguar Health 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GT Biopharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community prefer JAGX or GTBP? Jaguar Health received 1720 more outperform votes than GT Biopharma when rated by MarketBeat users. Likewise, 88.73% of users gave Jaguar Health an outperform vote while only 62.84% of users gave GT Biopharma an outperform vote. CompanyUnderperformOutperformJaguar HealthOutperform Votes183588.73% Underperform Votes23311.27%GT BiopharmaOutperform Votes11562.84% Underperform Votes6837.16% SummaryJaguar Health beats GT Biopharma on 8 of the 12 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get GT Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for GTBP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GTBP vs. The Competition Export to ExcelMetricGT BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.89M$6.48B$5.08B$8.80BDividend YieldN/A8.11%5.02%4.07%P/E RatioN/A4.9791.2813.60Price / SalesN/A371.451,226.2187.40Price / CashN/A52.5939.4536.27Price / Book3.2910.306.906.33Net Income-$7.60M$153.61M$118.83M$225.93M7 Day Performance3.00%-1.73%-1.92%-0.96%1 Month Performance27.69%-7.26%-3.75%1.06%1 Year Performance-55.22%31.10%31.37%26.59% GT Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GTBPGT Biopharma0.0716 of 5 stars$3.09-3.1%N/A-54.2%$6.89MN/A0.008JAGXJaguar Health0.6717 of 5 stars$0.97-0.9%N/A-96.5%$8.98M$9.76M0.0050KPRXKiora Pharmaceuticals2.9909 of 5 stars$3.42+5.9%$10.00+192.4%-32.4%$10.26MN/A0.0010CYADCelyad OncologyN/A$0.60flatN/A+0.0%$15.91M$110,000.000.0095High Trading VolumeTTPHTetraphase PharmaceuticalsN/A$2.20flatN/A+0.0%$15.98M$7.38M-0.10119UBXUnity Biotechnology3.6114 of 5 stars$1.16-1.1%$8.00+591.0%-42.1%$19.51M$240,000.000.0060RNXTRenovoRx2.6223 of 5 stars$1.13-5.0%$6.13+442.0%+98.7%$27.12MN/A-2.126News CoveragePositive NewsNAIINatural Alternatives International0.3468 of 5 stars$4.36-1.4%N/A-27.8%$27.03M$113.80M0.00290Analyst ForecastNews CoverageMRKRMarker Therapeutics3.8639 of 5 stars$3.01-5.3%$19.00+531.2%+17.8%$26.85M$3.31M0.0060DRRXDURECT3.0843 of 5 stars$0.86-4.8%$5.00+481.3%+39.5%$26.70M$8.55M0.0080Analyst ForecastAnalyst RevisionNews CoverageGap DownLGVNLongeveron2.3938 of 5 stars$1.85+0.0%$8.00+332.3%-90.4%$26.57M$710,000.000.0023 Related Companies and Tools Related Companies Jaguar Health Alternatives Kiora Pharmaceuticals Alternatives Celyad Oncology Alternatives Tetraphase Pharmaceuticals Alternatives Unity Biotechnology Alternatives RenovoRx Alternatives Natural Alternatives International Alternatives Marker Therapeutics Alternatives DURECT Alternatives Longeveron Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GTBP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GT Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GT Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
